SULWHASOO PERFECTING CUSHION NO. 37

Product NDC
43419-083
11-digit product format
434190083
Labeler code
43419
Product ID
43419-083_bf2647fd-bf12-93df-e053-2995a90a2432
Type
HUMAN OTC DRUG
Nonproprietary name
OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE
Dosage form
LOTION
Route
TOPICAL
Labeler
Amorepacific Corporation
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2019-07-15
Marketing end
0000-00-00
Substance
OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
Active strength
2 g/30g; g/30g; g/30g
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct43419-083DDiscontinued by firm2026-10-05
excluded packagepackage43419-08343419-083-31DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage43419-083-31d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage43419-083-31f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage43419-083-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage43419-083-31a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage43419-083-31cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage43419-083-31cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage43419-083-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage43419-083-31ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage43419-083-310efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage43419-083-31ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage43419-083-31367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage43419-083-31557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
777d68c6-a5ab-e06c-d314-677b0b9af0c8Product name220240508
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43419-083-31SULWHASOO PERFECTING CUSHION NO. 372 in 1 CARTONLOTION210
43419-083-31SULWHASOO PERFECTING CUSHION NO. 3715 g in 1 CONTAINERLOTION1510

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43419-083SULWHASOO PERFECTING CUSHION NO. 21 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 27 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 31 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 33 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 17 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 23 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 37 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 11 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION SULWHASOO PERFECTING CUSHION NO. 25 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC CORPORATION]9Legacy NDC, 2 package rows20241012_8d420e4b-c778-3ed4-e053-2995a90a59a9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SULWHASOO PERFECTING CUSHION NO. 15OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDEAmorepacific Corporation8d420e4b-c778-3ed4-e053-2995a90a59a92025-11-20WarningsExact identifier
ndc (product): 43419-083

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
43419-083-31434190083312 CONTAINER in 1 CARTON (43419-083-31) > 15 g in 1 CONTAINER2 container2019-07-150000-00-00NoNoCurrent